PMC:7094172 / 1322-4751
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T124 | 19-27 | CHEBI:36357;CHEBI:36357 | denotes | molecule |
T123 | 119-123 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T122 | 171-176 | NCBITaxon:10239 | denotes | viral |
T121 | 220-229 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
T120 | 309-324 | GO:0051260 | denotes | oligomerization |
T119 | 370-379 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
T118 | 383-391 | GO:0065007 | denotes | modulate |
T117 | 427-437 | CHEBI:35718;CHEBI:35718 | denotes | anticancer |
T116 | 438-442 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T115 | 443-453 | CHEBI:45863;CHEBI:45863 | denotes | paclitaxel |
T114 | 492-503 | GO:0005874;GO:0090307 | denotes | microtubule |
T113 | 504-522 | GO:0090307 | denotes | structure assembly |
T112 | 539-546 | PR:000028799 | denotes | tubulin |
T111 | 570-579 | CHEBI:33893;CHEBI:33893 | denotes | rapamycin |
T110 | 589-605 | CHEBI:67079;CHEBI:67079 | denotes | anticancer agent |
T109 | 647-653 | PR:000007536 | denotes | FKBP12 |
T108 | 699-706 | GO:0032991 | denotes | complex |
T107 | 767-771 | CHEBI:23888;CHEBI:23888;GO:0017144 | denotes | drug |
T106 | 772-783 | GO:0017144 | denotes | development |
T105 | 960-964 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T104 | 1099-1112 | PG_4 | denotes | nucleoprotein |
T103 | 1132-1141 | NCBITaxon:7719 | denotes | influenza |
T102 | 1142-1147 | NCBITaxon:10239 | denotes | virus |
T101 | 1175-1198 | GO:0051259 | denotes | protein oligomerization |
T100 | 1211-1216 | NCBITaxon:10239 | denotes | viral |
T99 | 1230-1241 | SP_9 | denotes | Middle East |
T98 | 1242-1253 | SP_9;UBERON:0001004 | denotes | respiratory |
T97 | 1254-1274 | SP_9 | denotes | syndrome coronavirus |
T96 | 1276-1284 | SP_9 | denotes | MERS-CoV |
T95 | 1301-1316 | SP_8;NCBITaxon:694002 | denotes | betacoronavirus |
T94 | 1351-1362 | UBERON:0001004 | denotes | respiratory |
T93 | 1402-1408 | NCBITaxon:9606 | denotes | humans |
T92 | 1449-1460 | NCBITaxon:11118 | denotes | coronavirus |
T91 | 1462-1473 | NCBITaxon:11118 | denotes | coronavirus |
T90 | 1488-1496 | SP_7 | denotes | COVID-19 |
T89 | 1750-1758 | SP_9 | denotes | MERS-CoV |
T88 | 1772-1778 | SO:0001026 | denotes | genome |
T87 | 1821-1838 | GO:0005840 | denotes | ribonucleoprotein |
T86 | 1845-1852 | GO:0032991 | denotes | complex |
T85 | 1879-1884 | NCBITaxon:10239 | denotes | viral |
T84 | 1948-1958 | GO:0065007 | denotes | modulation |
T83 | 1966-1967 | PG_4 | denotes | N |
T82 | 1968-1975 | PG_4;GO:0051259 | denotes | protein |
T81 | 1976-1991 | GO:0051259 | denotes | oligomerization |
T80 | 2001-2010 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
T79 | 2035-2039 | CHEBI:36044;CHEBI:36044 | denotes | drug |
T78 | 2071-2074 | NCBITaxon:11886 | denotes | CoV |
T77 | 2075-2084 | PG_4 | denotes | N protein |
T76 | 2118-2124 | SO:0000417 | denotes | domain |
T75 | 2150-2156 | SO:0000417 | denotes | domain |
T74 | 2174-2181 | SO:0000417 | denotes | domains |
T73 | 2353-2354 | GO:0051260;PG_4 | denotes | N |
T72 | 2355-2362 | PG_4;GO:0051259 | denotes | protein |
T71 | 2363-2378 | GO:0051259 | denotes | oligomerization |
T70 | 2459-2467 | SP_9 | denotes | MERS-CoV |
T69 | 2786-2790 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T68 | 2819-2835 | CHEBI:41237;CHEBI:41237 | denotes | benzyloxygramine |
T67 | 2894-2903 | PG_4 | denotes | N protein |
T66 | 3007-3008 | PG_4 | denotes | N |
T65 | 3009-3016 | PG_4;GO:0051259 | denotes | protein |
T64 | 3017-3032 | GO:0051259 | denotes | oligomerization |
T63 | 3100-3108 | SP_9 | denotes | MERS-CoV |
T62 | 3115-3124 | GO:0032991 | denotes | complexed |
T61 | 3130-3148 | CHEBI:41237;CHEBI:41237 | denotes | 5-benzyloxygramine |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T12 | 45-52 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T13 | 53-60 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T14 | 344-351 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T15 | 492-503 | Body_part | denotes | microtubule | http://purl.org/sig/ont/fma/fma63849 |
T16 | 539-546 | Body_part | denotes | tubulin | http://purl.org/sig/ont/fma/fma67116 |
T17 | 564-568 | Body_part | denotes | hand | http://purl.org/sig/ont/fma/fma9712 |
T18 | 1175-1182 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T19 | 1772-1778 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T20 | 1801-1808 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T21 | 1968-1975 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T22 | 2077-2084 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T23 | 2199-2202 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T24 | 2355-2362 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T25 | 2383-2390 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T26 | 2391-2398 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T27 | 2896-2903 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T28 | 2945-2949 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T29 | 3009-3016 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T30 | 3053-3057 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T31 | 3303-3310 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 564-568 | Body_part | denotes | hand | http://purl.obolibrary.org/obo/UBERON_0002398 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p35652s4 | 309-336 | MPA | denotes | oligomerization equilibrium |
p35652s8 | 344-351 | Protein | denotes | protein |
p35652s29 | 483-491 | PosReg | denotes | enhances |
p35652s30 | 492-522 | MPA | denotes | microtubule structure assembly |
p35655s32 | 1183-1198 | MPA | denotes | oligomerization |
p35655s34 | 1203-1207 | NegReg | denotes | loss |
p35655s37 | 1217-1226 | MPA | denotes | viability |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T7 | 171-187 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T8 | 1132-1141 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T9 | 1462-1486 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 1488-1496 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 1521-1530 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T12 | 2126-2129 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T14 | 2227-2230 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T16 | 2470-2473 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T18 | 3111-3114 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T20 | 3409-3419 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 87-96 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | extremely |
T11 | 885-892 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | extreme |
T12 | 922-923 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T13 | 1018-1026 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T14 | 1142-1147 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T15 | 1227-1229 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T16 | 1377-1378 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17 | 1402-1408 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T18 | 1425-1426 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T19 | 1782-1783 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T20 | 1819-1820 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T21 | 2014-2015 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T22 | 2088-2097 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organized |
T23 | 2256-2257 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 2477-2478 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T25 | 2760-2762 | http://purl.obolibrary.org/obo/CLO_0008285 | denotes | P1 |
T26 | 2876-2886 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T27 | 2945-2949 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T28 | 3053-3057 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T29 | 3242-3243 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T30 | 3290-3291 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T17 | 19-27 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T18 | 45-52 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T19 | 53-60 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T20 | 119-123 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T21 | 220-229 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T22 | 344-351 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T23 | 370-379 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T24 | 438-442 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T25 | 443-453 | Chemical | denotes | paclitaxel | http://purl.obolibrary.org/obo/CHEBI_45863 |
T26 | 570-579 | Chemical | denotes | rapamycin | http://purl.obolibrary.org/obo/CHEBI_9168 |
T27 | 589-605 | Chemical | denotes | anticancer agent | http://purl.obolibrary.org/obo/CHEBI_35610 |
T28 | 767-771 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T29 | 960-964 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T30 | 1008-1017 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T31 | 1057-1060 | Chemical | denotes | PPI | http://purl.obolibrary.org/obo/CHEBI_53266|http://purl.obolibrary.org/obo/CHEBI_60614 |
T33 | 1175-1182 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T34 | 1714-1730 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
T35 | 1801-1808 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T36 | 1968-1975 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T37 | 2001-2010 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T38 | 2025-2039 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T39 | 2025-2034 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T40 | 2035-2039 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T41 | 2077-2084 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T42 | 2355-2362 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T43 | 2383-2390 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T44 | 2391-2398 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T45 | 2606-2616 | Chemical | denotes | stabilizer | http://purl.obolibrary.org/obo/CHEBI_77966 |
T46 | 2760-2762 | Chemical | denotes | P1 | http://purl.obolibrary.org/obo/CHEBI_60949 |
T47 | 2786-2790 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T48 | 2850-2859 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T49 | 2896-2903 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T50 | 3009-3016 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T51 | 3303-3310 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 171-187 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
T3 | 1175-1198 | http://purl.obolibrary.org/obo/GO_0051259 | denotes | protein oligomerization |
T4 | 1879-1898 | http://purl.obolibrary.org/obo/GO_0019083 | denotes | viral transcription |
T5 | 1885-1898 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
T6 | 1968-1991 | http://purl.obolibrary.org/obo/GO_0051259 | denotes | protein oligomerization |
T7 | 2355-2378 | http://purl.obolibrary.org/obo/GO_0051259 | denotes | protein oligomerization |
T8 | 3009-3032 | http://purl.obolibrary.org/obo/GO_0051259 | denotes | protein oligomerization |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1351-1371 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T2 | 1521-1530 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 0-12 | Sentence | denotes | Introduction |
T11 | 13-134 | Sentence | denotes | Small-molecule stabilization of protein–protein interactions (PPIs) is an extremely promising strategy in drug discovery. |
T12 | 135-284 | Sentence | denotes | It can be used to treat cancers and viral infections.1−3 Stabilizing PPIs with small molecules may be allosteric or direct (also called orthosteric). |
T13 | 285-829 | Sentence | denotes | This process alters the oligomerization equilibrium of the protein and enables small molecules to modulate its physiological function.4−7 The anticancer drug paclitaxel, for example, allosterically enhances microtubule structure assembly by binding to β-tubulin.8,9 On the other hand, rapamycin, another anticancer agent, binds directly to the interface between FKBP12 and mTOR and stabilizes the structure of the complex.10 The most well-characterized PPIs suitable as targets for drug development form natively under physiological conditions. |
T14 | 830-973 | Sentence | denotes | However, non-native interactions, which may form under extreme circumstances such as inside a crystal lattice, are also potential drug targets. |
T15 | 974-1229 | Sentence | denotes | For example, nucleozin exerts its antiviral activity by stabilizing the non-native PPI interface between the two neighboring nucleoprotein trimers within the influenza virus, which results in abnormal protein oligomerization and loss of viral viability.11 |
T16 | 1230-1333 | Sentence | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) belongs to the betacoronavirus (β-CoVs) family. |
T17 | 1334-1668 | Sentence | denotes | It causes severe respiratory distress with a high mortality rate in humans.12−14 Recently, a closely related novel coronavirus, coronavirus disease 2019 (COVID-19), caused an outbreak of pneumonia in Wuhan, which further underscored the risk of CoVs to the global public health.15,16 However, there is no effective treatment for CoVs. |
T18 | 1669-1853 | Sentence | denotes | Thus, there is an urgent need to develop new antiviral agents against CoVs.14,17 MERS-CoV packages its genome in a nucleocapsid (N) protein and forms a ribonucleoprotein (RNP) complex. |
T19 | 1854-1912 | Sentence | denotes | The RNP is essential for viral transcription and assembly. |
T20 | 1913-2281 | Sentence | denotes | Several studies suggested that the modulation of CoV N protein oligomerization by small molecules is a feasible antiviral drug development strategy.18,19 The CoV N protein is organized into the N-terminal domain (NTD) and the C-terminal domain (CTD), with both domains participating in RNA binding.20,21 All CoV N-NTD structures are folded in a monomeric conformation. |
T21 | 2282-2417 | Sentence | denotes | In contrast, the CoV N-CTDs are always dimeric and are responsible for N protein oligomerization via protein–protein interactions.22,23 |
T22 | 2418-2512 | Sentence | denotes | Here, we report the crystal structure of MERS-CoV N-NTD in a non-native dimeric configuration. |
T23 | 2513-2617 | Sentence | denotes | We used the non-native dimer interface as the target in virtual screening for an orthosteric stabilizer. |
T24 | 2618-2801 | Sentence | denotes | To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases. |
T25 | 2802-2904 | Sentence | denotes | Of these, only 5-benzyloxygramine (P3) had both antiviral and stabilizing activities on the N protein. |
T26 | 2905-3064 | Sentence | denotes | Small-angle X-ray scattering (SAXS) and cell-based assays showed that P3 induces abnormal full-length N protein oligomerization in vitro and at the cell level. |
T27 | 3065-3188 | Sentence | denotes | We also described the structure of MERS-CoV N-NTD complexed with 5-benzyloxygramine and revealed its stabilizing mechanism. |
T28 | 3189-3333 | Sentence | denotes | Our findings provide insight into the development of a new therapeutic approach based on stabilizing a non-native protein interaction interface. |
T29 | 3334-3429 | Sentence | denotes | It may lead to the discovery and development of new treatments for various infectious diseases. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
22 | 647-653 | Gene | denotes | FKBP12 | Gene:2285 |
23 | 658-662 | Gene | denotes | mTOR | Gene:2475 |
24 | 1132-1147 | Species | denotes | influenza virus | Tax:11309 |
25 | 443-453 | Chemical | denotes | paclitaxel | MESH:D017239 |
26 | 570-579 | Chemical | denotes | rapamycin | MESH:D020123 |
27 | 987-996 | Chemical | denotes | nucleozin | |
28 | 159-166 | Disease | denotes | cancers | MESH:D009369 |
29 | 171-187 | Disease | denotes | viral infections | MESH:D001102 |
49 | 1840-1843 | Gene | denotes | RNP | Gene:55599 |
50 | 1858-1861 | Gene | denotes | RNP | Gene:55599 |
51 | 1230-1285 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
52 | 1301-1316 | Species | denotes | betacoronavirus | Tax:694002 |
53 | 1402-1408 | Species | denotes | humans | Tax:9606 |
54 | 1443-1460 | Species | denotes | novel coronavirus | Tax:2697049 |
55 | 1579-1583 | Species | denotes | CoVs | Tax:11118 |
56 | 1663-1667 | Species | denotes | CoVs | Tax:11118 |
57 | 1739-1743 | Species | denotes | CoVs | Tax:11118 |
58 | 1750-1758 | Species | denotes | MERS-CoV | Tax:1335626 |
59 | 1962-1965 | Species | denotes | CoV | Tax:11118 |
60 | 2071-2074 | Species | denotes | CoV | Tax:11118 |
61 | 2221-2224 | Species | denotes | CoV | Tax:11118 |
62 | 1318-1324 | Species | denotes | β-CoVs | Tax:694002 |
63 | 1351-1371 | Disease | denotes | respiratory distress | MESH:D012128 |
64 | 1462-1486 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
65 | 1488-1496 | Disease | denotes | COVID-19 | MESH:C000657245 |
66 | 1521-1530 | Disease | denotes | pneumonia | MESH:D011014 |
67 | 2299-2309 | Disease | denotes | CoV N-CTDs | MESH:C000657245 |
77 | 2459-2467 | Species | denotes | MERS-CoV | Tax:1335626 |
78 | 3100-3108 | Species | denotes | MERS-CoV | Tax:1335626 |
79 | 2760-2765 | Chemical | denotes | P1–P3 | |
80 | 2817-2835 | Chemical | denotes | 5-benzyloxygramine | MESH:C006736 |
81 | 2837-2839 | Chemical | denotes | P3 | |
82 | 2975-2977 | Chemical | denotes | P3 | |
83 | 3109-3114 | Chemical | denotes | N-NTD | |
84 | 3130-3148 | Chemical | denotes | 5-benzyloxygramine | MESH:C006736 |
85 | 3409-3428 | Disease | denotes | infectious diseases | MESH:D003141 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32105468-28968506-61929489 | 190-191 | 28968506 | denotes | 3 |
32105468-30957264-61929490 | 419-420 | 30957264 | denotes | 4 |
32105468-30913483-61929491 | 421-422 | 30913483 | denotes | 7 |
32105468-28283069-61929492 | 707-709 | 28283069 | denotes | 10 |
32105468-29268608-61929493 | 1227-1229 | 29268608 | denotes | 11 |
32105468-23075143-61929494 | 1409-1411 | 23075143 | denotes | 12 |
32105468-32402160-61929495 | 1612-1614 | 32402160 | denotes | 15 |
32105468-31953166-61929496 | 1615-1617 | 31953166 | denotes | 16 |
32105468-31099550-61929497 | 1747-1749 | 31099550 | denotes | 17 |
32105468-26691874-61929498 | 2061-2063 | 26691874 | denotes | 18 |
32105468-26868298-61929499 | 2064-2066 | 26868298 | denotes | 19 |
32105468-25105276-61929500 | 2211-2213 | 25105276 | denotes | 20 |
32105468-27344959-61929501 | 2214-2216 | 27344959 | denotes | 21 |
32105468-24564608-61929502 | 2412-2414 | 24564608 | denotes | 22 |
32105468-30644840-61929503 | 2415-2417 | 30644840 | denotes | 23 |